| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 6,822,948 | 8,292,427 | 7,729,036 | | Cost of Revenue | 5,503,469 | 6,370,293 | 5,907,022 | | | Gross Profit | 1,319,479 | 1,922,135 | 1,822,014 | | | Operating Expenses | | Research Development | 331,280 | 424,195 | 368,364 | | Selling General and Administrative | 937,451 | 1,028,084 | 889,882 | | Non Recurring | 1,887,588 | (44,187) | (93,741) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,836,839) | 514,042 | 657,509 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (411,632) | 22,094 | (566,409) | | Earnings Before Interest And Taxes | (2,397,900) | 537,609 | 91,101 | | Interest Expense | 152,248 | 176,748 | 142,592 | | Income Before Tax | (2,550,147) | 360,861 | (51,492) | | Income Tax Expense | 149,428 | 39,768 | 29,047 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,550,147) | 321,092 | (80,538) | | | Non-recurring Events | | Discontinued Operations | (174,803) | (354,969) | (182,201) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,724,950) | (33,877) | (262,740) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,724,950) | ($33,877) | ($262,740) |
|
0.31% Nasdaq 
Income Statement
